Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02186431 · ClinicalTrials.gov registry record · NA
Contact Lenses and Infiltrative Keratitis
A NA study, sponsored by State University of New York College of Optometry.
- Completed
- Registry status
- NA
- Development phase
- 32
- Enrollment target
NCT02186431 is a NA study that has completed, run by State University of New York College of Optometry. The registered enrollment target is 32 participants.
The verdict
NCT02186431, a NA study, has completed, sponsored by State University of New York College of Optometry.
- COMPLETED
- Registry status
- NA
- Development phase
- 32 participants
- Enrollment target
Study Summary
To quantify and compare baseline tear proteins and ocular response in contact lens wearers with a history of corneal infiltrative events, to those without a history of complications. This will be accomplished via measurement of select anti-inflammatory tear proteins before, during and after contact lens wear.
Interventions
- DEVICE senofilcon A
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 32 participants |
| Start Date | 2014-07 |
| Est. Completion | 2016-05 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02186431
The ClinicalTrials.gov registry entry for NCT02186431 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 32 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is State University of New York College of Optometry, which has 14 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which senofilcon A is the first listed.
NCT02186431 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02186431 about?
NCT02186431 is a clinical study titled "Contact Lenses and Infiltrative Keratitis". To quantify and compare baseline tear proteins and ocular response in contact lens wearers with a history of corneal infiltrative events, to those without a history of complications. This will be accomplished via measurement of select anti-inflammatory tear proteins before, during and after contact ...
What is the current status of trial NCT02186431?
This trial is currently completed. It is a NA study. The enrollment target is 32 participants. The study started on 2014-07. Estimated completion is 2016-05.
What interventions are being tested in trial NCT02186431?
The interventions under investigation include: senofilcon A (DEVICE).
Who is sponsoring clinical trial NCT02186431?
This trial is sponsored by State University of New York College of Optometry, which has 14 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.